The R&D heads of over 25 global biopharmaceutical companies have signed a joint letter expressing alarm over the impact of the Biden administration's new prescription medicine price negotiation power. …
Global R&D heads sign joint letter expressing alarm over new pricing power
October 20, 2023 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
AI and the fine print of the government's 'Health Products Portal'
September 25, 2026 - - Latest News -
If AI causes a breach of confidentiality protections, who is to blame?
September 25, 2026 - - Latest News -
Pharmac opens patient recruitment to new advisory committee
September 25, 2026 - - Latest News -
Boehringer Ingelheim stays in Macquarie Park with new ANZ headquarters
September 25, 2026 - - Latest News -
Canberra is outraged that AI accessed data without asking - others know the feeling
September 24, 2026 - - Latest News -
England's genomics chief to share NHS lessons during Australia visit
September 24, 2026 - - Latest News -
AI is already in the decision-making process, but where is the conversation about its use?
September 24, 2026 - - Latest News